Global Bone and Joint Regenerative Medicines Market Growth (Status and Outlook) 2021-2026
- Category: Medical
- Published Date: Oct 2021
- Publisher: LP Information
- Pages: 87
According to this latest study, the 2021 growth of Bone and Joint Regenerative Medicines will have significant change from previous year. By the most conservative estimates of global Bone and Joint Regenerative Medicines market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Bone and Joint Regenerative Medicines market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone and Joint Regenerative Medicines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Biomaterials
Stem Cell Therapy
Tissue Engineering
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Ambulatory Surgical Centers
Hospitals
Specialty Orthopedic Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Anika Therapeutics
Arthrex
Baxter International
CONMED Corporation
Johnson & Johnson
Medtronic plc
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings, Inc.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone and Joint Regenerative Medicines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Biomaterials
Stem Cell Therapy
Tissue Engineering
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Ambulatory Surgical Centers
Hospitals
Specialty Orthopedic Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Anika Therapeutics
Arthrex
Baxter International
CONMED Corporation
Johnson & Johnson
Medtronic plc
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings, Inc.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bone and Joint Regenerative Medicines Market Size 2016-2026
2.1.2 Bone and Joint Regenerative Medicines Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Bone and Joint Regenerative Medicines Segment by Type
2.2.1 Biomaterials
2.2.2 Biomaterials
2.2.3 Tissue Engineering
2.3 Bone and Joint Regenerative Medicines Market Size by Type
2.3.1 Global Bone and Joint Regenerative Medicines Market Size CAGR by Type
2.3.2 Global Bone and Joint Regenerative Medicines Market Size Market Share by Type (2016-2021)
2.4 Bone and Joint Regenerative Medicines Segment by Application
2.4.1 Ambulatory Surgical Centers
2.4.2 Hospitals
2.4.3 Specialty Orthopedic Clinic
2.5 Bone and Joint Regenerative Medicines Market Size by Application
2.5.1 Global Bone and Joint Regenerative Medicines Market Size CAGR by Application
2.5.2 Global Bone and Joint Regenerative Medicines Market Size Market Share by Application (2016-2021)
3 Bone and Joint Regenerative Medicines Market Size by Players
3.1 Bone and Joint Regenerative Medicines Market Size Market Share by Players
3.1.1 Global Bone and Joint Regenerative Medicines Revenue by Players (2019-2021E)
3.1.2 Global Bone and Joint Regenerative Medicines Revenue Market Share by Players (2019-2021E)
3.2 Global Bone and Joint Regenerative Medicines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bone and Joint Regenerative Medicines by Regions
4.1 Bone and Joint Regenerative Medicines Market Size by Regions (2016-2021)
4.2 Americas Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
4.3 APAC Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
4.4 Europe Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
4.5 Middle East & Africa Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
5 Americas
5.1 Americas Bone and Joint Regenerative Medicines Market Size by Country (2016-2021)
5.2 Americas Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
5.3 Americas Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone and Joint Regenerative Medicines Market Size by Region (2016-2021)
6.2 APAC Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
6.3 APAC Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bone and Joint Regenerative Medicines by Country (2016-2021)
7.2 Europe Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
7.3 Europe Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bone and Joint Regenerative Medicines by Region (2016-2021)
8.2 Middle East & Africa Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
8.3 Middle East & Africa Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Bone and Joint Regenerative Medicines Market Forecast
10.1 Global Bone and Joint Regenerative Medicines Forecast by Regions (2021-2026)
10.1.1 Global Bone and Joint Regenerative Medicines Forecast by Regions (2021-2026)
10.1.2 Americas Bone and Joint Regenerative Medicines Forecast
10.1.3 APAC Bone and Joint Regenerative Medicines Forecast
10.1.4 Europe Bone and Joint Regenerative Medicines Forecast
10.1.5 Middle East & Africa Bone and Joint Regenerative Medicines Forecast
10.2 Americas Bone and Joint Regenerative Medicines Forecast by Countries (2021-2026)
10.2.1 United States Bone and Joint Regenerative Medicines Market Forecast
10.2.2 Canada Bone and Joint Regenerative Medicines Market Forecast
10.2.3 Mexico Bone and Joint Regenerative Medicines Market Forecast
10.2.4 Brazil Bone and Joint Regenerative Medicines Market Forecast
10.3 APAC Bone and Joint Regenerative Medicines Forecast by Region (2021-2026)
10.3.1 China Bone and Joint Regenerative Medicines Market Forecast
10.3.2 Japan Bone and Joint Regenerative Medicines Market Forecast
10.3.3 Korea Bone and Joint Regenerative Medicines Market Forecast
10.3.4 Southeast Asia Bone and Joint Regenerative Medicines Market Forecast
10.3.5 India Bone and Joint Regenerative Medicines Market Forecast
10.3.6 Australia Bone and Joint Regenerative Medicines Market Forecast
10.4 Europe Bone and Joint Regenerative Medicines Forecast by Country (2021-2026)
10.4.1 Germany Bone and Joint Regenerative Medicines Market Forecast
10.4.2 France Bone and Joint Regenerative Medicines Market Forecast
10.4.3 UK Bone and Joint Regenerative Medicines Market Forecast
10.4.4 Italy Bone and Joint Regenerative Medicines Market Forecast
10.4.5 Russia Bone and Joint Regenerative Medicines Market Forecast
10.5 Middle East & Africa Bone and Joint Regenerative Medicines Forecast by Region (2021-2026)
10.5.1 Egypt Bone and Joint Regenerative Medicines Market Forecast
10.5.2 South Africa Bone and Joint Regenerative Medicines Market Forecast
10.5.3 Israel Bone and Joint Regenerative Medicines Market Forecast
10.5.4 Turkey Bone and Joint Regenerative Medicines Market Forecast
10.5.5 GCC Countries Bone and Joint Regenerative Medicines Market Forecast
10.6 Global Bone and Joint Regenerative Medicines Forecast by Type (2021-2026)
10.7 Global Bone and Joint Regenerative Medicines Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Anika Therapeutics
11.1.1 Anika Therapeutics Company Information
11.1.2 Anika Therapeutics Bone and Joint Regenerative Medicines Product Offered
11.1.3 Anika Therapeutics Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Anika Therapeutics Main Business Overview
11.1.5 Anika Therapeutics Latest Developments
11.2 Arthrex
11.2.1 Arthrex Company Information
11.2.2 Arthrex Bone and Joint Regenerative Medicines Product Offered
11.2.3 Arthrex Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Arthrex Main Business Overview
11.2.5 Arthrex Latest Developments
11.3 Baxter International
11.3.1 Baxter International Company Information
11.3.2 Baxter International Bone and Joint Regenerative Medicines Product Offered
11.3.3 Baxter International Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Baxter International Main Business Overview
11.3.5 Baxter International Latest Developments
11.4 CONMED Corporation
11.4.1 CONMED Corporation Company Information
11.4.2 CONMED Corporation Bone and Joint Regenerative Medicines Product Offered
11.4.3 CONMED Corporation Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 CONMED Corporation Main Business Overview
11.4.5 CONMED Corporation Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Bone and Joint Regenerative Medicines Product Offered
11.5.3 Johnson & Johnson Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Medtronic plc
11.6.1 Medtronic plc Company Information
11.6.2 Medtronic plc Bone and Joint Regenerative Medicines Product Offered
11.6.3 Medtronic plc Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Medtronic plc Main Business Overview
11.6.5 Medtronic plc Latest Developments
11.7 Smith & Nephew plc
11.7.1 Smith & Nephew plc Company Information
11.7.2 Smith & Nephew plc Bone and Joint Regenerative Medicines Product Offered
11.7.3 Smith & Nephew plc Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Smith & Nephew plc Main Business Overview
11.7.5 Smith & Nephew plc Latest Developments
11.8 Stryker Corporation
11.8.1 Stryker Corporation Company Information
11.8.2 Stryker Corporation Bone and Joint Regenerative Medicines Product Offered
11.8.3 Stryker Corporation Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Stryker Corporation Main Business Overview
11.8.5 Stryker Corporation Latest Developments
11.9 Zimmer Biomet Holdings, Inc.
11.9.1 Zimmer Biomet Holdings, Inc. Company Information
11.9.2 Zimmer Biomet Holdings, Inc. Bone and Joint Regenerative Medicines Product Offered
11.9.3 Zimmer Biomet Holdings, Inc. Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Zimmer Biomet Holdings, Inc. Main Business Overview
11.9.5 Zimmer Biomet Holdings, Inc. Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bone and Joint Regenerative Medicines Market Size 2016-2026
2.1.2 Bone and Joint Regenerative Medicines Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Bone and Joint Regenerative Medicines Segment by Type
2.2.1 Biomaterials
2.2.2 Biomaterials
2.2.3 Tissue Engineering
2.3 Bone and Joint Regenerative Medicines Market Size by Type
2.3.1 Global Bone and Joint Regenerative Medicines Market Size CAGR by Type
2.3.2 Global Bone and Joint Regenerative Medicines Market Size Market Share by Type (2016-2021)
2.4 Bone and Joint Regenerative Medicines Segment by Application
2.4.1 Ambulatory Surgical Centers
2.4.2 Hospitals
2.4.3 Specialty Orthopedic Clinic
2.5 Bone and Joint Regenerative Medicines Market Size by Application
2.5.1 Global Bone and Joint Regenerative Medicines Market Size CAGR by Application
2.5.2 Global Bone and Joint Regenerative Medicines Market Size Market Share by Application (2016-2021)
3 Bone and Joint Regenerative Medicines Market Size by Players
3.1 Bone and Joint Regenerative Medicines Market Size Market Share by Players
3.1.1 Global Bone and Joint Regenerative Medicines Revenue by Players (2019-2021E)
3.1.2 Global Bone and Joint Regenerative Medicines Revenue Market Share by Players (2019-2021E)
3.2 Global Bone and Joint Regenerative Medicines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bone and Joint Regenerative Medicines by Regions
4.1 Bone and Joint Regenerative Medicines Market Size by Regions (2016-2021)
4.2 Americas Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
4.3 APAC Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
4.4 Europe Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
4.5 Middle East & Africa Bone and Joint Regenerative Medicines Market Size Growth (2016-2021)
5 Americas
5.1 Americas Bone and Joint Regenerative Medicines Market Size by Country (2016-2021)
5.2 Americas Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
5.3 Americas Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone and Joint Regenerative Medicines Market Size by Region (2016-2021)
6.2 APAC Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
6.3 APAC Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bone and Joint Regenerative Medicines by Country (2016-2021)
7.2 Europe Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
7.3 Europe Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bone and Joint Regenerative Medicines by Region (2016-2021)
8.2 Middle East & Africa Bone and Joint Regenerative Medicines Market Size by Type (2016-2021)
8.3 Middle East & Africa Bone and Joint Regenerative Medicines Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Bone and Joint Regenerative Medicines Market Forecast
10.1 Global Bone and Joint Regenerative Medicines Forecast by Regions (2021-2026)
10.1.1 Global Bone and Joint Regenerative Medicines Forecast by Regions (2021-2026)
10.1.2 Americas Bone and Joint Regenerative Medicines Forecast
10.1.3 APAC Bone and Joint Regenerative Medicines Forecast
10.1.4 Europe Bone and Joint Regenerative Medicines Forecast
10.1.5 Middle East & Africa Bone and Joint Regenerative Medicines Forecast
10.2 Americas Bone and Joint Regenerative Medicines Forecast by Countries (2021-2026)
10.2.1 United States Bone and Joint Regenerative Medicines Market Forecast
10.2.2 Canada Bone and Joint Regenerative Medicines Market Forecast
10.2.3 Mexico Bone and Joint Regenerative Medicines Market Forecast
10.2.4 Brazil Bone and Joint Regenerative Medicines Market Forecast
10.3 APAC Bone and Joint Regenerative Medicines Forecast by Region (2021-2026)
10.3.1 China Bone and Joint Regenerative Medicines Market Forecast
10.3.2 Japan Bone and Joint Regenerative Medicines Market Forecast
10.3.3 Korea Bone and Joint Regenerative Medicines Market Forecast
10.3.4 Southeast Asia Bone and Joint Regenerative Medicines Market Forecast
10.3.5 India Bone and Joint Regenerative Medicines Market Forecast
10.3.6 Australia Bone and Joint Regenerative Medicines Market Forecast
10.4 Europe Bone and Joint Regenerative Medicines Forecast by Country (2021-2026)
10.4.1 Germany Bone and Joint Regenerative Medicines Market Forecast
10.4.2 France Bone and Joint Regenerative Medicines Market Forecast
10.4.3 UK Bone and Joint Regenerative Medicines Market Forecast
10.4.4 Italy Bone and Joint Regenerative Medicines Market Forecast
10.4.5 Russia Bone and Joint Regenerative Medicines Market Forecast
10.5 Middle East & Africa Bone and Joint Regenerative Medicines Forecast by Region (2021-2026)
10.5.1 Egypt Bone and Joint Regenerative Medicines Market Forecast
10.5.2 South Africa Bone and Joint Regenerative Medicines Market Forecast
10.5.3 Israel Bone and Joint Regenerative Medicines Market Forecast
10.5.4 Turkey Bone and Joint Regenerative Medicines Market Forecast
10.5.5 GCC Countries Bone and Joint Regenerative Medicines Market Forecast
10.6 Global Bone and Joint Regenerative Medicines Forecast by Type (2021-2026)
10.7 Global Bone and Joint Regenerative Medicines Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Anika Therapeutics
11.1.1 Anika Therapeutics Company Information
11.1.2 Anika Therapeutics Bone and Joint Regenerative Medicines Product Offered
11.1.3 Anika Therapeutics Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Anika Therapeutics Main Business Overview
11.1.5 Anika Therapeutics Latest Developments
11.2 Arthrex
11.2.1 Arthrex Company Information
11.2.2 Arthrex Bone and Joint Regenerative Medicines Product Offered
11.2.3 Arthrex Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Arthrex Main Business Overview
11.2.5 Arthrex Latest Developments
11.3 Baxter International
11.3.1 Baxter International Company Information
11.3.2 Baxter International Bone and Joint Regenerative Medicines Product Offered
11.3.3 Baxter International Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Baxter International Main Business Overview
11.3.5 Baxter International Latest Developments
11.4 CONMED Corporation
11.4.1 CONMED Corporation Company Information
11.4.2 CONMED Corporation Bone and Joint Regenerative Medicines Product Offered
11.4.3 CONMED Corporation Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 CONMED Corporation Main Business Overview
11.4.5 CONMED Corporation Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Bone and Joint Regenerative Medicines Product Offered
11.5.3 Johnson & Johnson Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Medtronic plc
11.6.1 Medtronic plc Company Information
11.6.2 Medtronic plc Bone and Joint Regenerative Medicines Product Offered
11.6.3 Medtronic plc Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Medtronic plc Main Business Overview
11.6.5 Medtronic plc Latest Developments
11.7 Smith & Nephew plc
11.7.1 Smith & Nephew plc Company Information
11.7.2 Smith & Nephew plc Bone and Joint Regenerative Medicines Product Offered
11.7.3 Smith & Nephew plc Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Smith & Nephew plc Main Business Overview
11.7.5 Smith & Nephew plc Latest Developments
11.8 Stryker Corporation
11.8.1 Stryker Corporation Company Information
11.8.2 Stryker Corporation Bone and Joint Regenerative Medicines Product Offered
11.8.3 Stryker Corporation Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Stryker Corporation Main Business Overview
11.8.5 Stryker Corporation Latest Developments
11.9 Zimmer Biomet Holdings, Inc.
11.9.1 Zimmer Biomet Holdings, Inc. Company Information
11.9.2 Zimmer Biomet Holdings, Inc. Bone and Joint Regenerative Medicines Product Offered
11.9.3 Zimmer Biomet Holdings, Inc. Bone and Joint Regenerative Medicines Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Zimmer Biomet Holdings, Inc. Main Business Overview
11.9.5 Zimmer Biomet Holdings, Inc. Latest Developments
12 Research Findings and Conclusion
no record found